Ann: EuGeni Test Strip Manufacturing Strategy, page-62

The market looks like it has expressed its view on this announcement, down 3c.

A manufacturing facility at Anteo may be possible in the present building if there is vacant space down stairs. For those who have not been there Anteo occupies most of the upstairs of a 2 story building. The facility will need to be constructed to provide a quality controlled processes, including a sophisticated cool room and the reel to reel plant. This will take good design, attention to detail and effort. The concept is good, especially for future test production.

So why is the market not impressed. There is the belated nature of the strategy. More importantly it is now 6 weeks since announcement of CE Mark approval of the Covid test. The market is now saying we need some significant sales feedback. Until then we ADO supporters will see the price linger in the 25c to 35c range. Then depending on the significance of any sales data or not there will be a re-rating. At the good end over 50c a share may be to $1.

One may ask how can such a high price be justified. The answer is that this will be the proof of concept that will start to attract other players to the technology in a serious way.

Until there are sales we will all sit closely to the edge of our seats. Get moving Anteo board and management.